chrisvoncsefalvay/vaers-outcomes huggingface dataset:
woke up morning p/vax w/hard breathing, gasping for air, feeling nauseated & uncomfortable;was seen @ clinic & given 2 APAP;sx subsided w/each passing hr;pt can & has eaten eggs;
Shot administered to patient with majority of dose discharged out side of lure lock of syringe for administration.  Readministered vaccine to patient.
Patient received moderna vaccine on 1/19/22 and the pfizer vaccine on 1/26/21, 2/15/21 and 5/25/22. Presented to ER on 6/20/22 and found to be COVID positive. admitted for fever caused by cellulitis of the right lower extremity vs UTI vs COVID-19, and AKI. On initial presentation patients vitals were stable. Labs showed leukocytosis, elevated inflammatory markers, UA showing 3+ LE, elevated BNP, and elevated Cr at 2.1 COVID-19 positive (6/20/2022). CXR showed pulmonary vascular congestion and bilateral lower extremity dopplers were negative for DVT. Patient was admitted for further management for right lower extremity cellulitis, UTI, COVID-19, and AKI. For COVID-19 patient was initially saturating well on room with no difficulty not requiring any oxygen. A few days after being admitted patient was having shortness of breathing requiring supplemental oxygen. While being placed on oxygen she continued to saturate >95% and was weaned down. CXR's were repeated more than once that was not showing pneumonia, but eventually showed a new consolidation that was suspicious for pneumonia and increased pulmonary edema. Patient was already being treated with clindamycin which gave coverage for pneumonia. Patient received a one time dose of lasix for pulmonary edema. Respiratory status was monitored throughout admission where patient would need up to 4LNC with worsening shortness of breath. Patient was treated with decadron for up to 3 days. She was continuously weaned off oxygen throughout her stay. Prior to discharge, patient was saturating at 89-90% on room air. Due to patients returning to a nursing home, a 6 minute oxygen walk was not required due to nursing home having there own protocol. Discharged on 6/28/22
At approximately 16:23 (15 minutes after receiving Pfizer pediatric covid-19 vaccination) patient developed a few pinkish spots at forehead only.  This RN immediately assessed patient who denied difficulty breathing or shortness of breath.  Spo2 on room air was 100% with a respiration of 20 breaths per minute, and heart rate of 101.  Patient was given 10 mL of children's benadryl (12.5mg/5mL) and advised to remain an additional 20 minutes for observation.  At 16:45, pinkish areas on forehead improved, patient states "I feel better."  Vital signs stable (see chart).  This RN advised mother for patient to seek medical attention for worsening symptoms (ie- shortness of breath/difficulty breathing).  Patient denied any pain, shortness of breath and in no distress at this time and was discharged with mother at 16:48.
pregnant patient got Shingrix; 34YO patient got Shingrix; This prospective pregnancy case was reported by a other health professional via call center representative and described the occurrence of vaccine exposure during pregnancy in a 34-year-old female patient who received Herpes zoster (Shingrix) (batch number AC4CK, expiry date 14th September 2023) for prophylaxis.   On 4th August 2022, the patient received Shingrix. The patient's last menstrual period was on an unknown date and estimated date of delivery was 16th December 2022. The patient received Shingrix at an unknown time during the pregnancy. On 4th August 2022, unknown after receiving Shingrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the patient experienced vaccine exposure during pregnancy. On an unknown date, the outcome of the vaccine exposure during pregnancy and inappropriate age at vaccine administration were unknown. The pregnancy was ongoing.  Additional Information: GSK Receipt Date: 04-AUG-2022 Reporter's Comments: The patient received Shingrix by mistake and wanted to know about the risks and adverse events for Shingrix while being pregnant. The patient was 12 weeks and 5 days pregnant at the time of reporting. The reporter consented to follow up. Additional Supportive Information: The patient received Shingrix while being pregnant, which led to vaccine exposure during pregnancy. The patient received vaccine earlier than the recommended age, which led to inappropriate age at vaccine administration.
Moderna COVID-19 vaccine  Received shot 8am on a Thursday morning. Friday at 3am  Began having chills about 16 hrs after injection and fever4 hours later of 102. Also had headache and leg pains. Fever lasted until 8am Saturday morning. Then just had fatigue for 2 days. I took Tylenol and ibuprofen alternating.
Left arm feels like he is experiencing a "moderate sunburn"; A sore left arm; Red around the injection site; Tender area around the injection site; A headache that lasted 4 hours; 2nd dose was given less than 26 days after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was given less than 26 days after 1st dose), RASH ERYTHEMATOUS (Left arm feels like he is experiencing a "moderate sunburn"), HEADACHE (A headache that lasted 4 hours), VACCINATION SITE PAIN (A sore left arm) and VACCINATION SITE ERYTHEMA (Red around the injection site) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pacemaker insertion (cardiac) in March 2018 and Stent insertion NOS in March 2018. Concurrent medical conditions included Blood calcium increased, Cardiac disorder, High cholesterol and Drug allergy. Concomitant products included VITAMINS NOS, ATORVASTATIN, SOTALOL, APIXABAN (ELIQUIS) and DILTIAZEM for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was given less than 26 days after 1st dose) and HEADACHE (A headache that lasted 4 hours). On 28-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Left arm feels like he is experiencing a "moderate sunburn"), VACCINATION SITE PAIN (A sore left arm), VACCINATION SITE ERYTHEMA (Red around the injection site) and VACCINATION SITE PAIN (Tender area around the injection site). On 23-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was given less than 26 days after 1st dose) had resolved, HEADACHE (A headache that lasted 4 hours) outcome was unknown. At the time of the report, RASH ERYTHEMATOUS (Left arm feels like he is experiencing a "moderate sunburn"), VACCINATION SITE PAIN (A sore left arm), VACCINATION SITE ERYTHEMA (Red around the injection site) and VACCINATION SITE PAIN (Tender area around the injection site) outcome was unknown.            No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Hives, fever, feeling faint hot flashes, nausea fatigue clammy
Dizzy; Symptoms included temperature; Sweating; Chills; Headache; Stomach ache; Weakness; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 13Jan2021 at 11:00, at a single dose, for COVID-19 immunization. The patient's medical and concomitant medications were not reported. On 13Jan2021 at 11:00 AM, the patient had a human exposure from the COVID-19 vaccine. The patient received the COVID-19 vaccine on Wednesday at 11 AM. On 13Jan2021 at 11 AM, the following symptoms included temperature, sweating, chills, headache, stomach ache, weakness, and dizzy. The following first aid measures have been taken. The patient went to the emergency room last night where they advised her to self-quarantine. The outcome of the events was unknown.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
On 9/21/96, I fell in my bedroom, against a swivel rocker and it propelled me against my dresser. My son took me to the ER where I had 11 stitches on my mouth. I was bleeding profusely. I preferred not to take a Tetanus shot and didn't think it necessary. I am allergic to sulfa and penicillin, also Chloromycetin, therefore I abhor shots. The doctor and the nurse on duty talked me into taking the shot. I keep a diary and on 9/28/96, 1 week after receiving the shot, I wrote in my diary that "I am so tired this morning, I have a big bunch on my right arm, just below my shoulder. It must be from the tetanus shot." I have very little use of my right arm and gradually the strength in my legs is going, much of the time. I carry a cane and my balance is not good. A year after the shot, my arm locked and pained. My PCP wanted me to go for therapy but I couldn't drive. I have been doing exercises and get by. I have had 5 years of misery and I feel it may be from the tetanus shot. I realize I am old, but I don't think I would be so handicapped if I hadn't had the shot.
The night He received injection, He Had intense Pain To His Left Arm. Could not Lift it. Pain Lasted 72 hours. Out of work For 48 Hours.
pt recvd vax & inadvertent administration is reported in a pt who recvd flu vax
2/16/23 I had symptoms of a cold. I had congestion, slight sore throat, weariness, and some muscle aches. I had this for four or five days. I had a positive COVID at home test on 2/19/23. I had a telehealth on 2/20/23 and was prescribed PAXLOVID, but I never took it because I felt better.
I was out of breath, hands were shaking, everything went dark, I believe I passed out (I started to have weak legs in a store and left the store and went to my car.  I was alone and sat in my car.).  When I got to the car I put my head on the steering wheel, believed I passed out for a short time, woke up and stayed in my car for 15-20 minutes and then drove home.  When I got home I laid down and felt normal again about an hour later.
shingles; any and all of its sequelae/ other related health complications; was 47 (conflict information, also reported as 48) years old when he received the zoster vaccine live (ZOSTAVAX); Information has been received from a lawyer referring to a 47 years old male patient regarding a case in litigation. Information about concurrent condition, history condition and concomitant medication was not reported. On 16-MAR-2017(conflict information, also reported as at 48 years old), the patient was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, anatomical location, lot# and expiration date unknown) at a health facility for prophylaxis (Inappropriate schedule of product administration). On 08-OCT-2017, as a result of his receipt of zoster vaccine live (ZOSTAVAX), the patient was caused to suffer serious and dangerous side effects including shingles, including any and all of its sequelae (also reported as other related health complications)(Ill-defined disorder), as well as other severe and personal injuries. The patient had been caused to suffer other severe personal injuries which were permanent and lasting in nature, physical pain and mental anguish, including diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications. The patient also had suffered and would continue to suffer diminished capacity for the enjoyment of life, a diminished quality of life, increased risk of premature death, aggravation of preexisting conditions, activation of latent conditions, and other losses and damages. The patient required and/or would require more health care and services. The patient had incurred and would continue to incur medical and related expenses. The patient's direct medical losses and costs include physician care, monitoring, and treatment. The patient had also incurred and would continue to incur mental and physical pain and suffering. The outcome of shingles and ill-defined disorder was considered as not recovered.  These events of shingles and ill-defined disorder  were considered as disability by the lawyer.
Patient lost motor control in vaccinated arm. She was examined by a physician. Movement came back and symptoms have resolved now.
Varicella; Asthenia / fatigue; headache, pulmonary congestion - Information has been received from a health care professional concerning a 50 year old caucasian female patient with osteoporosis, depression, hypercholesterolemia, asthma, allergies to penicillin, sulfa and nuts and a history of hip surgery and fractures who on 06 mar 2000 was vaccinated sc at the left deltoid with a first dose of varicella virus vaccine live lot 631166/0708J.  Concomitant therapy included alendronate sodium (MSD).  omeprazola prilosec estrogens estorified (estratab), venlafaxine hydrochlorid (effexor), flouxetine hydrochloride prozac, pravastatin sodium pravachol, fluticasone propionstel flovent, zafirlukast accolate, eslmoterol 1- hydroxy 2- naphthoate serevent, albuterol sulfate (+) ipratropium bromide combivent. calcium supplement (nos), multivitamins, antioxidant tables and ascorbic acid. on 18 mar 2000 the patient experiented fatigue, requiring extended naps, mild headache, chest congestion and per sistent typical chickenpx lsions clustered at the left deltoid, posterior neck, right eyebrow, right thigh and mid back.  It was noted that the patient was afebrile.  The patient was seen in the physician's office.  Follow up information reported that the patient recovered on 17 Mar 2000 and the plan is to check a varicella IgG in late April 2000.  It was also noted that the patient was evaluated by an infectious disease specialist on 20 mar 2000. no further information is available at this time.
Information has been received from a physician concerning a 24 year old male who on an unspecified date was vaccinated with VARIVAX. About ten days after vaccination, the patient developed generalized, diffuse varicella rash with low grade fever. It was unspecified if patient sought medical attention. At the time of the reporting, the patient had recovered. Additional information has been requested.
extreme chills to the point where my teeth were chattering even though I was wearing winter clothes and multiple blankets, disabling body aches and headache, chest pain when breathing, nausea - all for about 24 to 36 hours
Pain, redness, swelling of (L) deltoid about 10 hours after injection; went to urgent care 2 days later and was put on cephalexin 500 mg 1 cap TID x 10 days.
Information has been received from a 30 year old female patient who on an unspecified date was vaccinated with a dose of MERUVAX II vaccine. Subsequently the patient had a reaction (not specified) to the vaccine. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.
Received Moderna vaccine on 2/29/21 and 3/19/2021. Health began declining 2 weeks later and died on 4/13/2021 (26 days post vaccination) with heart failure listed as cause of death.
MD relayed that post vax child developed circles, red on outside with bruise color in center. Took to another MD at a pediatric center was ? diagnosed. Took to a children's ER on 2/23/03 was Dx'd with erythema multiforme. Child was on antibiotic at time of vax.
Symptoms started having trouble walking within a few days and vaccine was given 9/17/18, then few days without issues and then 9/24/18 muscle weakness worsened, 9/30/18 she lost ability to walk, paralysis waist down, ended up on bipap, now in skilled nursing home to recover strength, diagnosed with Guillain Barre.
The day of vaccination general malaise and low grade fever which resolved with Motrin.   Four days after woke up with chest pain.  Presented to ER where he was found to have elavated troponin 1.01. EKG showed Normal sinus rhythm, with ST elevation.
sore arm; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and PAIN IN EXTREMITY (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) and PAIN IN EXTREMITY (sore arm) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 23-OCT-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB (exposed to the following temperatures and cumulative time frames colder than 36F: In September of 2015, the coldest temperature was 34F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34F for 192 hours, for a total of 1,031.3 hours (43 days)) with lot number: L010595, expiry date: 12-NOV-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Initial swelling around injection site, then itching red rash developed around injection site 5 days later and fussy more than usual. Seen in our office on 5-12-04 with 3cm area of induration with excoriation.
Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Severe, Systemic: Seizure-Medium, Additional Details: after patient was given vaccine, he slumped into chair and fell over and started having a seizure. seizure lasted for about 10 seconds and regained consciousness. paramedics were called and he was taken to the hospital. patient said that he had an extreme fair of needles and that he had fainted that last time he got a vaccine.
Information has been received, via the Merck pregnancy registry, from an approximately 20 year old female consumer (date of birth given, but onset of events and vaccination/gestation dates not specified), who was vaccinated with the first and second dose of GRADASIL (dates and lot # not reported). Subsequently, "between my second and third dose I was pregnant and ultimately miscarried." The patient sought medical attention, and was seen in an office visit (details not specified). The consumer questioned if miscarriage was a possible side effect of GARDASIL. The date of the third dose was not clarified as before or after miscarriage. The outcome of miscarriage was not specified. Upon internal review, ultimately miscarried was considered to be serious as an other important medical event. No further information was available.
Myalgia, Fever,  abdominal pain, chills, fatigue Narrative:
10 patients received doses from an expire vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 patients received doses from an expire vial) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054C21A and 054C214) for COVID-19 vaccination.     No Medical History information was reported.   On 27-May-2021 at 2:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021 at 2:49 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 patients received doses from an expire vial). On 24-Jun-2021, EXPIRED PRODUCT ADMINISTERED (10 patients received doses from an expire vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not reported.  Treatment information was not provided.
When I  was drawing up 4 year vaccine . The  Assistant of that doctor in which i was helping with vaccine, told me to do COVID VACCINE to another Room Also. I misheard  and understood they were 7 years old. I drew up 5-11 PFIZER vaccine instead of  6month- 4 years MODERNA vaccine and administered to 4 year old patient.
Information has been received from a 49 year old female consumer referring to herself. The patient had no pertinent medical history or drug reactions/allergies. "2 years ago", in approximately December 2013 the patient was vaccinated with a dose of PNEUMOVAX 23 (lot#, dose and route not reported, indication reported as respiratory asthma). Concomitant therapies included ZYRTEC. On an unspecified date the patient was tested for immunity to pneumococcal disease and did not show immunity after receiving PNEUMOVAX 23. Her allergist recommended that she got revaccinated. After revaccination of PNEUMOVAX 23 (lot#, dose and route not reported) on 18-DEC-2015, she experienced severe arm pain which woke her from her sleep on the same day. She also stated that she could not lift or move her arm at night (on 18-DEC-2015). She experienced pain from the tip of her toes and throughout her body (on 18-DEC-2015) which lasted three days. She stated that the pain had improved significantly but was still mild. The patient also stated that since receiving the revaccination, she had experienced heavier than usual menstrual bleeding which appeared to get worse every day (started on 18-DEC-2015). The bleeding was so heavy that, "it felt like peeing". She also noticed clotting in her menstruation (started on 18-DEC-2015). The patient had sought medical attention from physical therapist for arm pain. She was treated with MOTRIN. At time of this reporting, outcome of the events "arm pain" and "pain from the tip of her toes and throughout her body" was considered as recovering (improved but still mild). Outcome of the other events was unknown. The causality was not provided. Additional information is not expected because the physician did not want to be contacted.